Results 31 to 40 of about 2,328,071 (294)

Super Mean Labeling of Some Classes of Graphs [PDF]

, 2012
Approaching topics as Smarandachely super m-mean labeling, Smarandachely super m-mean graph, super mean labeling, super mean ...
P.Jeyanthi, D.Ramya, Jeyanthi, P., Ramya, D.   +3 more
core   +1 more source

Super Fibonacci Graceful Labeling [PDF]

, 2011
Approaching topics such as Smarandache-Fibonacci triple, graceful labeling, Fibonacci graceful labeling, super Smarandache-Fibonacci graceful graph, super Fibonacci graceful ...
Sridevi, R., Navaneethakrishnan, S., Nagarajan, K.   +2 more
core   +1 more source

Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015

Frontiers in Pharmacology, 2019
Background: Recent studies in several countries show a significant decrease in the consumption of osteoporosis drugs from a peak around 2009, mainly attributed to bisphosphonate safety warnings issued by regulatory agencies on jaw osteonecrosis, atypical
Isabel Hurtado-Navarro, Isabel Hurtado-Navarro, Aníbal García-Sempere, Aníbal García-Sempere, Clara Rodríguez-Bernal, Clara Rodríguez-Bernal, José Sanfélix-Genovés, José Sanfélix-Genovés, Salvador Peiró, Salvador Peiró, Gabriel Sanfélix-Gimeno, Gabriel Sanfélix-Gimeno   +11 more
doaj   +1 more source

Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non‐orphan drugs approved by the FDA

Clinical and Translational Science, 2022
Clinical pharmacology is an integral discipline supporting the development, regulatory evaluation, and clinical use of drugs for the treatment of both common and rare diseases.
Julie Hsieh, Martina Sahre, Xinning Yang, Rajanikanth Madabushi, Anuradha Ramamoorthy   +4 more
doaj   +1 more source

A Comparative Study of Drug Package Inserts of High Selling Cardiac Drugs against the Drug Regulations of Iranian Food and Drug Administration [PDF]

Taṣvīr-i salāmat, 2019
Background and Objectives: The Drug Package Insert (PI) is a written information provided by drug manufacturers to deliver essential information for the consumer.
Sedigheh Mirzadeh Qasabeh, Vahideh Zareh Gavgani   +1 more
doaj  

Cardiovascular Drug Labeling: Do They Have Information on Necessary Precautions for Older People? [PDF]

Geriatrics, Gerontology and Aging
OBJECTIVE: To analyze the existence of information on drug labeling intended for health professionals on the precaution of cardiovascular drugs use in older people.
Lucas Oliveira Marques, Roberta Coutinho Vasconcelos, André Oliveira Baldoni, Ana Cristina Nogueira Rodrigues Pestana, Farah Maria Drumond Chequer   +4 more
doaj   +1 more source

Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021

Pharmaceutics, 2022
Understanding possible follow-up actions on in vitro findings helps determine the necessity of labeling for drug interactions. We analyzed information for in vitro findings on transporter-mediated interactions of drugs approved by the U.S.
Kyeong-Ryoon Lee, Ji-Eun Chang, Jongmin Yoon, Hyojeong Jin, Yoon-Jee Chae   +4 more
doaj   +1 more source

Current practices in organization of anesthesia drug tray

Asian Journal of Medical Sciences, 2022
Background: The risk of medication error is high in the operating room, since the anesthesiologist prepares, stores, and administers the medication. Poor labeling practices and cluttered drug trays increase the risk of syringe swap and medication error ...
Sowmya Jois , Sowmya Madihalli Janardhan Iyengar , Mahesh Chandra , Rangalakshmi Srinivasan , Arunkumar Namachivayam   +4 more
doaj   +1 more source

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

Pediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz, Se Whee Sammy Park, Aironas Los, Ernest Liu, Nona Struyf, Tom Erkers, Sören Lehmann, Jan J. Molenaar, Jakob Stenman, Olli Kallioniemi, Päivi Östling, Brinton Seashore‐Ludlow, Kasper Karlsson   +12 more
wiley   +1 more source

The processes of reform in Victoria’s alcohol and other drug sector, 2011-2014 [PDF]

, 2014
This paper explores issues and concerns related to the 2014 alcohol and other drug sector recommissioning process in Victoria. Overview In mid-2014, the Victorian Alcohol and Drug Association approached the Drug Policy Modelling Program, at the ...
Drug Policy Modelling Program
core